Hey Chong

2.1k total citations
35 papers, 649 citations indexed

About

Hey Chong is a scholar working on Immunology, Infectious Diseases and Genetics. According to data from OpenAlex, Hey Chong has authored 35 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 8 papers in Infectious Diseases and 7 papers in Genetics. Recurrent topics in Hey Chong's work include Immunodeficiency and Autoimmune Disorders (14 papers), Mast cells and histamine (6 papers) and Blood disorders and treatments (5 papers). Hey Chong is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (14 papers), Mast cells and histamine (6 papers) and Blood disorders and treatments (5 papers). Hey Chong collaborates with scholars based in United States, Canada and Czechia. Hey Chong's co-authors include Christopher P. Shelburne, Paria Mirmonsef, L. Andrew Bouton, Daniel P. Bailey, Georges Leclercq, Olga V. Naidenko, Frederik Stevenaert, Laurent Brossay, Carlos Ramírez and Marlowe S. Tessmer and has published in prestigious journals such as Blood, The Journal of Immunology and PEDIATRICS.

In The Last Decade

Hey Chong

31 papers receiving 642 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hey Chong United States 13 442 125 108 104 98 35 649
A K Matsumoto United States 8 495 1.1× 33 0.3× 165 1.5× 78 0.8× 85 0.9× 11 740
W.‐K. Hofmann Germany 15 304 0.7× 58 0.5× 248 2.3× 55 0.5× 110 1.1× 22 905
Meggan Czapiga United States 11 263 0.6× 148 1.2× 225 2.1× 35 0.3× 82 0.8× 14 637
Jesús Villarrubia Spain 15 520 1.2× 304 2.4× 158 1.5× 203 2.0× 46 0.5× 45 1.0k
Paloma Pérez‐Aciego Spain 15 561 1.3× 45 0.4× 172 1.6× 42 0.4× 126 1.3× 28 855
Tom Horan United States 12 827 1.9× 90 0.7× 129 1.2× 49 0.5× 222 2.3× 13 1.0k
J Sloan-Lancaster United States 8 733 1.7× 65 0.5× 146 1.4× 50 0.5× 150 1.5× 9 971
Shuji Ohta Japan 12 147 0.3× 56 0.4× 115 1.1× 32 0.3× 65 0.7× 24 586
Dzung T. Le United States 11 230 0.5× 63 0.5× 278 2.6× 62 0.6× 42 0.4× 15 778
John Scopes United Kingdom 13 211 0.5× 53 0.4× 291 2.7× 24 0.2× 196 2.0× 18 756

Countries citing papers authored by Hey Chong

Since Specialization
Citations

This map shows the geographic impact of Hey Chong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hey Chong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hey Chong more than expected).

Fields of papers citing papers by Hey Chong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hey Chong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hey Chong. The network helps show where Hey Chong may publish in the future.

Co-authorship network of co-authors of Hey Chong

This figure shows the co-authorship network connecting the top 25 collaborators of Hey Chong. A scholar is included among the top collaborators of Hey Chong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hey Chong. Hey Chong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dorsey, Morna J., Manish J. Butte, Jay R. Lieberman, et al.. (2025). Multi-Year Registry Study of Elapegademase Treatment in Patients With Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID) Requiring Enzyme Replacement Therapy. Journal of Clinical Immunology. 45(1). 84–84.
2.
Crawford, Erin L., et al.. (2024). 35 Identification of a novel XIAP pathogenic variant associated with XIAP deficiency presenting as VEOIBD. Clinical Immunology. 262. 109977–109977.
3.
Chong, Hey, et al.. (2024). Inborn Errors of Immunity. Medical Clinics of North America. 108(4). 703–718. 2 indexed citations
4.
Chong, Hey, et al.. (2023). Inborn Errors of Immunity. Primary Care Clinics in Office Practice. 50(2). 253–268. 5 indexed citations
5.
Chong, Hey, et al.. (2023). Newborn Screening for Severe Combined Immunodeficiency. 7(3). 1–7.
6.
Samarakoon, Upeka, Xiaoqing Fu, Alexei Gonzalez‐Estrada, et al.. (2022). Anaphylaxis after COVID-19 vaccination: A registry-based study. The Journal of Allergy and Clinical Immunology In Practice. 10(11). 3020–3023. 5 indexed citations
7.
James, Alyssa, Amanda Urban, Jason Raasch, et al.. (2022). Treatment of STAT3-deficient hyper–immunoglobulin E syndrome with monoclonal antibodies targeting allergic inflammation. The Journal of Allergy and Clinical Immunology In Practice. 10(5). 1367–1370.e1. 13 indexed citations
8.
Connelly, James A., Hey Chong, Adam J. Esbenshade, et al.. (2021). Impact of COVID-19 on Pediatric Immunocompromised Patients. Pediatric Clinics of North America. 68(5). 1029–1054. 16 indexed citations
9.
Knight, Vijaya, Jennifer Heimall, Hey Chong, et al.. (2021). A Toolkit and Framework for Optimal Laboratory Evaluation of Individuals with Suspected Primary Immunodeficiency. The Journal of Allergy and Clinical Immunology In Practice. 9(9). 3293–3307.e6. 11 indexed citations
10.
Eddens, Taylor, et al.. (2021). Trends in Pediatric Primary Immunodeficiency: Incidence, Utilization, Transplantation, and Mortality. The Journal of Allergy and Clinical Immunology In Practice. 10(1). 286–296.e3. 4 indexed citations
11.
Prince, Benjamin T., Beth K Thielen, Kelli W. Williams, et al.. (2020). <p>Geographic Variability and Pathogen-Specific Considerations in the Diagnosis and Management of Chronic Granulomatous Disease</p>. Pediatric Health Medicine and Therapeutics. Volume 11. 257–268. 5 indexed citations
12.
Burk, Caitlin M., Emily M. Mace, Bret L. Bostwick, et al.. (2019). Immunodeficiency, centromeric instability, and facial anomalies (ICF) syndrome with NK dysfunction and EBV-driven malignancy treated with stem cell transplantation. The Journal of Allergy and Clinical Immunology In Practice. 8(3). 1103–1106.e3. 6 indexed citations
13.
Chong, Hey. (2017). SEVERE COMBINED IMMUNE DEFICIENCY (SCID): NEED FOR UNIVERSAL NEWBORN SCREENING (NBS) IN PENNSYLVANIA (PA). 1 indexed citations
14.
Srinath, Arvind I., Suneeta Madan‐Khetarpal, Marianne McGuire, et al.. (2017). Aplastic anemia and cytotoxic T lymphocyte antigen-4 haploinsufficiency treated with bone marrow transplantation. The Journal of Allergy and Clinical Immunology In Practice. 5(5). 1445–1447.e2. 5 indexed citations
15.
Chong, Hey, et al.. (2013). A case of a false-positive screen for severe combined immunodeficiency in Pennsylvania, a state without statewide screening. The Journal of Allergy and Clinical Immunology In Practice. 1(4). 407–408. 2 indexed citations
16.
Fanning, Laura B., Hey Chong, José Martínez-Fernández, et al.. (2011). Desensitization regimens for drug allergy: state of the art in the 21st century. Clinical & Experimental Allergy. 41(12). 1679–1689. 85 indexed citations
17.
Tessmer, Marlowe S., Frederik Stevenaert, Olga V. Naidenko, et al.. (2007). KLRG1 binds cadherins and preferentially associates with SHIP-1. International Immunology. 19(4). 391–400. 89 indexed citations
18.
Chong, Hey, Carlos Ramírez, Christopher P. Shelburne, et al.. (2004). IL-10 Inhibits FcεRI Expression in Mouse Mast Cells. The Journal of Immunology. 172(5). 3181–3188. 57 indexed citations
19.
Chong, Hey, L. Andrew Bouton, Daniel P. Bailey, et al.. (2003). IL-4 selectively enhances FcγRIII expression and signaling on mouse mast cells. Cellular Immunology. 224(2). 65–73. 17 indexed citations
20.
Shelburne, Christopher P., Margaret E. McCoy, Roland P. Piekorz, et al.. (2002). Stat5: an essential regulator of mast cell biology. Molecular Immunology. 38(16-18). 1187–1191. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A K Matsumoto Breakdown of academic impact, for papers by W.‐K. Hofmann Breakdown of academic impact, for papers by Meggan Czapiga Breakdown of academic impact, for papers by Jesús Villarrubia Breakdown of academic impact, for papers by Paloma Pérez‐Aciego Breakdown of academic impact, for papers by Tom Horan Breakdown of academic impact, for papers by J Sloan-Lancaster Breakdown of academic impact, for papers by Shuji Ohta Breakdown of academic impact, for papers by Dzung T. Le Breakdown of academic impact, for papers by John Scopes
Rankless by CCL
2026